<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-id journal-id-type="hwp">nar</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17636049</article-id><article-id pub-id-type="pmc">PMC1976452</article-id><article-id pub-id-type="doi">10.1093/nar/gkm520</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>G-quadruplex induced stabilization by 2&#x02032;-deoxy-2&#x02032;-fluoro-<sc>d</sc>-arabinonucleic acids (2&#x02032;F-ANA)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Chang Geng</given-names></name></contrib><contrib contrib-type="author"><name><surname>Damha</surname><given-names>Masad J.</given-names></name><xref ref-type="corresp" rid="COR1">*</xref></contrib></contrib-group><aff>Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, QC, Canada H3A 2K6</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed:<phone>+1-514-398-7552</phone><fax>+1-514-398-3797</fax><email>masad.damha@mcgill.ca</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>17</day><month>7</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>7</month><year>2007</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>35</volume><issue>15</issue><fpage>4977</fpage><lpage>4988</lpage><history><date date-type="received"><day>28</day><month>4</month><year>2007</year></date><date date-type="rev-recd"><day>13</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; 2007 The Author(s)</copyright-statement><copyright-year>2007</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The impact of 2<bold>&#x02032;</bold>-deoxy-2<bold>&#x02032;</bold>-fluoroarabinonucleotide residues (2<bold>&#x02032;</bold>F-araN) on different G-quadruplexes derived from a thrombin-binding DNA aptamer d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>), an anti-HIV phosphorothioate aptamer PS-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) and a DNA telomeric sequence d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) via UV thermal melting (<italic>T</italic><sub>m</sub>) and circular dichroism (CD) experiments has been investigated. Generally, replacement of deoxyguanosines that adopt the <italic>anti</italic> conformation (<italic>anti</italic>-guanines) with 2<bold>&#x02032;</bold>F-araG can stabilize G-quartets and maintain the quadruplex conformation, while replacement of <italic>syn</italic>-guanines with 2<bold>&#x02032;</bold>F-araG is not favored and results in a dramatic switch to an alternative quadruplex conformation. It was found that incorporation of 2<bold>&#x02032;</bold>F-araG or T residues into a thrombin-binding DNA G-quadruplex stabilizes the complex (&#x00394;<italic>T</italic><sub>m</sub> up to <bold>&#x0223c;</bold>+3&#x000b0;C/2<bold>&#x02032;</bold>F-araN modification); 2<bold>&#x02032;</bold>F-araN units also increased the half-life in 10% fetal bovine serum (FBS) up to 48-fold. Two modified thrombin-binding aptamers (PG13 and PG14) show an approximately 4-fold increase in binding affinity to thrombin, as assessed via a nitrocellulose filter binding assay, both with increased thermal stability (<bold>&#x0223c;</bold>1&#x000b0;C/2<bold>&#x02032;</bold>F-ANA modification increase in <italic>T</italic><sub>m</sub>) and nuclease resistance (4&#x02013;7-fold) as well. Therefore, the 2<bold>&#x02032;</bold>-deoxy-2<bold>&#x02032;</bold>-fluoro-<sc>d</sc>-arabinonucleic acid (2<bold>&#x02032;</bold>F-ANA) modification is well suited to tune (and improve) the physicochemical and biological properties of naturally occurring DNA G-quartets.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>Guanine quartet (G-quartet) structures with four Hoogsteen-paired, coplanar guanines were first observed more than 40 years ago (<xref ref-type="bibr" rid="B1">1</xref>) and later demonstrated to be a unique structural motif of guanine-rich oligonucleotides (<xref ref-type="bibr" rid="B2">2</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>A). G-quartets are found in nature and also in sequences identified by screening techniques such as <italic>Systematic Evolution of Ligands by EXponential enrichment</italic> (<italic>SELEX</italic>) (<xref ref-type="bibr" rid="B3 B4 B5">3&#x02013;5</xref>). They have also aroused interest as therapeutic agents to inhibit human thrombin (<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>), HIV infection (<xref ref-type="bibr" rid="B7 B8 B9">7&#x02013;9</xref>), and as targets themselves to inhibit telomerase activity in anticancer drug design (<xref ref-type="bibr" rid="B10">10</xref>).
<fig id="F1" position="float"><label>Figure 1.</label><caption><p>Structure of (<bold>A</bold>) G-quartet with cyclic array of four guanines linked by Hoogsteen H-bonds (<xref ref-type="bibr" rid="B1">1</xref>); (<bold>B</bold>) thrombin-binding DNA d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>) with an edge-loop (chair-like) unimolecular G-quadruplex in K<sup>+</sup> (<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>); (<bold>C)</bold> a telomeric DNA d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) with diagonal-loop dimeric hairpin complex [d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>)]<sub>2</sub> in Na<sup>+</sup> (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>); (D) a tetrameric G-quadruplex [d(PS-T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>)]<sub>4</sub> with four parallel strands (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>).</p></caption><graphic xlink:href="gkm520f1"/></fig></p><p>G-quartets display extraordinary structural polymorphism (<xref ref-type="bibr" rid="B11 B12 B13">11&#x02013;13</xref>). The 15-nt DNA sequence d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>) (<xref ref-type="bibr" rid="B6">6</xref>) binds and inactivate thrombin, a key enzyme in the blood clotting cascade. NMR spectroscopy reveals that it adopts a uniquely folded structure with two stacked G-quartets connected through edge-loops (one TGT and two TT loops) involving antiparallel alignment of adjacent strands (<xref ref-type="fig" rid="F1">Figure 1</xref>B) (<xref ref-type="bibr" rid="B14 B15 B16 B17">14&#x02013;17</xref>). A seemly different crystal structure of this aptamer&#x02013;thrombin complex (<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>) was later analyzed to be in agreement with the previous NMR structure (<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>). Potassium ions stabilize the G-quadruplex by coordination to the G residues (<xref ref-type="bibr" rid="B15">15</xref>). The G-quartet displays an alternating <italic>syn</italic> and <italic>anti</italic> conformation of guanine bases (<italic>syn</italic>- and <italic>anti</italic>-Gs) on the same plane and 5&#x02032;-<italic>syn</italic>-G/3&#x02032;-<italic>anti</italic>-G along each strand of the quadruplex (i.e. 5&#x02032;-<italic>syn</italic>-<italic>anti</italic>-3&#x02032; connectivity where <italic>syn</italic>-G includes G1, G5, G10 and G14 and <italic>anti</italic>-G includes G2, G6, G11 and G15 in <xref ref-type="fig" rid="F1">Figure 1</xref>B) and all the thymidines are in the <italic>anti</italic> orientation (<xref ref-type="bibr" rid="B15">15</xref>).</p><p>The telomeric sequence d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) adopts symmetrical dimeric quadruplexes comprising four G-quartets linked through a diagonal loop as analyzed by NMR in sodium (Na<sup>+</sup>) environment (<xref ref-type="fig" rid="F1">Figure 1</xref>C) (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>) or an edge-loop structure as revealed by X-crystallography in potassium (K<sup>+</sup>) environment (<xref ref-type="bibr" rid="B23">23</xref>). More recent studies re-examined the crystal structure of this sequence and suggested the crystal structure also adopts a diagonal conformation, consistent with the NMR solution structure (<xref ref-type="bibr" rid="B24">24</xref>). The diagonal loop configuration (<xref ref-type="fig" rid="F1">Figure 1</xref>C) consists of <italic>5</italic>&#x02032;-<italic>syn</italic>-G<italic>/</italic>3&#x02032;-<italic>anti</italic>-G along each G-strand, <italic>syn-syn-anti-anti</italic> conformations in a G-quartet and all sugar residues puckered in the <italic>south</italic> (C2&#x02032;-<italic>endo)</italic> conformation (<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>).</p><p>Another interesting example is the phosphorothioate oligonucleotide PS-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) identified as an inhibitor of HIV-1 infection <italic>in vitro</italic> by combinatorial screening of a library of DNA strands. This aptamer inhibits HIV envelope-mediated cell fusion <italic>in vitro</italic> and its structure consists of a parallel-stranded tetramer with all guanines in the <italic>anti</italic>-conformation (<xref ref-type="fig" rid="F1">Figure 1</xref>D) (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>).</p><p>Based on the above, the glycosidic conformations of guanines (i.e. <italic>syn</italic>- and <italic>anti</italic>-Gs) have a strong correlation with strand alignments. Parallel-stranded quadruplexes (<xref ref-type="fig" rid="F1">Figure 1</xref>D) support only <italic>anti</italic>-G residues, while antiparallel-stranded quadruplexes favor alternating <italic>syn-anti</italic> Gs engaged in unimolecular (<xref ref-type="fig" rid="F1">Figure 1</xref>B) or intermolecular complexes (<xref ref-type="fig" rid="F1">Figure 1</xref>C) (<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B26">26</xref>).</p><p>G-quadruplexes are sensitive to chemical modifications. Several studies aimed at modifying the thrombin-binding aptamer d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>) have been reported (<xref ref-type="bibr" rid="B27 B28 B29 B30 B31">27&#x02013;31</xref>), but very few, if any, have led to an improvement over the original molecule. For example, Seela and coworkers recently reported the insertion of a hairpin-forming sequence GCGAAG into the position of the central loop (TGT) of the thrombin-binding aptamer. This construct formed a G-quadruplex fused to a mini-hairpin structure. According to the <italic>T</italic><sub>m</sub> data, the mini-hairpin induces a structural change in the aptamer section, leading to less stable G-quadruplex. Binding to thrombin was not investigated (<xref ref-type="bibr" rid="B30">30</xref>). Sacc&#x000e0; <italic>et al</italic>. studied the effect of backbone charge and atom size, base substitutions as well as the effect of modification at the sugar 2&#x02032;-position as analyzed by spectroscopy. Fully modified aptamers with sugar modifications (ribose, 2&#x02032;-<italic>O</italic>-methylribose) and phosphate backbone modifications (methylphosphonate, phosphorothioate) led to a reduction in the thermal stability (<xref ref-type="bibr" rid="B31">31</xref>). In fact, the 2&#x02032;-<italic>O</italic>-methylribose modification led not only to a destabilization of the structure but to a complete transformation of the G-tetrad conformation, as shown by spectroscopy in potassium buffer (<xref ref-type="bibr" rid="B31">31</xref>). 2&#x02032;-<italic>O</italic>-methylribose was also shown to causes structural changes in RNA aptamers and often resulted in a loss of activity (<xref ref-type="bibr" rid="B32">32</xref>). Accordingly, there is a need for new chemical modifications to improve the nuclease stability of this and other aptamers. Ideally, these modifications will not alter the subtle binding interactions of the selected native aptamers and the thermal stability of G-quadruplexes.</p><p>2&#x02032;-Deoxy-2&#x02032;-fluoro-<sc>d</sc>-arabinonucleic acids (2&#x02032;F-ANA) confer DNA-like (<italic>South/East)</italic> conformations (<xref ref-type="bibr" rid="B33">33</xref>) to oligonucleotides while rendering them more nuclease resistant (<xref ref-type="bibr" rid="B34">34</xref>). The incorporation of 2&#x02032;F-araN units in oligonucleotides also raises the <italic>T</italic><sub>m</sub> of different systems, i.e. duplexes (&#x0223c;+1&#x000b0;C/nt) (<xref ref-type="bibr" rid="B35">35</xref>), triplexes (&#x0223c;+0.8&#x000b0;C/nt) (<xref ref-type="bibr" rid="B36">36</xref>) and C-rich quadruplexes (&#x0223c;+1&#x000b0;C/nt, pH &#x0003c;4.0) (<xref ref-type="bibr" rid="B37">37</xref>). In light of this and other advantageous characteristics of 2F-ANA, such as synthetic accessibility through conventional solid-phase phosphoramidite chemistry, and promising antisense/siRNA properties (<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B38 B39 B40">38&#x02013;40</xref>), we have undertaken the first study concerning the ability of 2&#x02032;F-ANA to form various G-quadruplex structures as analyzed by <italic>T</italic><sub>m</sub> and CD experiments. 2&#x02032;F-ANA modified thrombin-binding aptamers were further evaluated by their nuclease resistance and binding affinity to thrombin. The outcome of these studies has opened new perspectives for the application of 2&#x02032;F-ANA as aptamer oligonucleotides.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Chemical synthesis of oligonucleotides</title><p>The sequence and composition of the oligomers prepared in this study are shown in <xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>. Arabinose modified aptamer syntheses were carried out at a 1&#x02009;&#x003bc;mol scale on an Applied Biosystems (ABI) 3400A synthesizer using standard &#x003b2;-cyanoethylphosphoramidite chemistry according to published protocols (<xref ref-type="bibr" rid="B41">41</xref>). Deoxyribonucleoside phosphoramidites were purchased from ChemGenes (Waltham, MA) and 2&#x02032;F-arabinonucleoside 3&#x02032;-<italic>O</italic>-phosphoramidites were provided by Topigen Pharmaceuticals Inc. (Montreal, Canada). The final concentrations of the monomers were 0.10&#x02009;M for 2&#x02032;-deoxyribonucleoside phosphoramidites and 0.125&#x02009;M for the 2&#x02032;F-arabinose phosphoramidites. The coupling time was extended to 150&#x02009;s for the 2&#x02032;-deoxyribonucleoside phosphoramidites dC and dG, and 15&#x02009;min for the 2&#x02032;F-araG and T phosphoramidites. These conditions gave about 99% average stepwise coupling yields. With the exception of PG17 through PG24, oligonucleotides were purified by anion-exchange HPLC (Waters Protein Pak DEAE-5PW column; 7.5 mm &#x000d7; 7.5&#x02009;cm), desalted by size-exclusion chromatography on Sephadex G-25 resin, and characterized by MALDI-TOF mass spectrometry (Kratos Kompact-III Instrument; Kratos Analytical Inc., New York). Purity of the isolated oligonucleotides was &#x0003e;95% by HPLC. PG17&#x02013;24 were used as obtained following deprotection and desalting.
<table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>Sequences, CD, <italic>T</italic><sub>m</sub> and binding data of 2&#x02032;F-ANA modified thrombin-binding aptamers</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Code</th><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Sequence<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th rowspan="1" colspan="1"><italic>T</italic><sub>m</sub> (&#x00394;<italic>T</italic><sub>m</sub>)<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref> (&#x000b0;C)</th><th rowspan="1" colspan="1">CD type<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th><th rowspan="1" colspan="1">Hysterisis in <italic>T</italic><sub>m</sub><xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></th><th rowspan="1" colspan="1">K<sub>d</sub> (nM)<xref ref-type="table-fn" rid="TF5"><sup>e</sup></xref></th><th rowspan="1" colspan="1"><italic>t</italic><sub>1/2</sub> (h)<xref ref-type="table-fn" rid="TF6"><sup>f</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">PG1</td><td rowspan="1" colspan="1">All DNA</td><td rowspan="1" colspan="1">d(GGTTGGTGTGGTTGG)</td><td rowspan="1" colspan="1">46.4 <sup>(42)</sup></td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">210</td><td rowspan="1" colspan="1">0.5</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">47.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">200<sup>(6)</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PG2</td><td rowspan="1" colspan="1">All 2&#x02032;F-ANA</td><td rowspan="1" colspan="1">d(<bold>GGTTGGTGTGGTTGG</bold>)</td><td rowspan="1" colspan="1">54.1 (+0.4)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">yes</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">&#x0003e;24</td></tr><tr><td rowspan="1" colspan="1">PG3</td><td rowspan="1" colspan="1">2&#x02032;F-ANA G-<italic>anti</italic></td><td rowspan="1" colspan="1">d(G<bold>G</bold>TTG<bold>G</bold>TGTG<bold>G</bold>TTG<bold>G</bold>)</td><td rowspan="1" colspan="1">53.3 (+1.5)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">&#x0003e;700</td><td rowspan="1" colspan="1">4.8</td></tr><tr><td rowspan="1" colspan="1">PG4</td><td rowspan="1" colspan="1">2&#x02032;F-ANA G-<italic>anti</italic>&#x00026; loop</td><td rowspan="1" colspan="1">d(G<bold>GTT</bold>G<bold>GTGT</bold>G<bold>GTT</bold>G<bold>G</bold>)</td><td rowspan="1" colspan="1">61.6 (+1.3)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">9.4</td></tr><tr><td rowspan="1" colspan="1">PG5</td><td rowspan="1" colspan="1">2&#x02032;F-ANA G-<italic>syn</italic></td><td rowspan="1" colspan="1">d(<bold>G</bold>GTT<bold>G</bold>GTGT<bold>G</bold>GTT<bold>G</bold>G)</td><td rowspan="1" colspan="1">45.4 (&#x02013;&#x02009;0.5)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">yes</td><td rowspan="1" colspan="1">&#x0003e;700</td><td rowspan="1" colspan="1">0.8</td></tr><tr><td rowspan="1" colspan="1">PG6</td><td rowspan="1" colspan="1">2&#x02032;F-ANA G-<italic>syn</italic>&#x00026;loop</td><td rowspan="1" colspan="1">d(<bold>G</bold>G<bold>TTG</bold>G<bold>TGTG</bold>G<bold>TTG</bold>G)</td><td rowspan="1" colspan="1">48.5 (+0.1)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">yes</td><td rowspan="1" colspan="1">&#x0003e;700</td><td rowspan="1" colspan="1">0.6</td></tr><tr><td rowspan="1" colspan="1">PG7</td><td rowspan="1" colspan="1">2&#x02032;F-ANA G-quartet</td><td rowspan="1" colspan="1">d(<bold>GG</bold>TT<bold>GG</bold>TGT<bold>GG</bold>TT<bold>GG</bold>)</td><td rowspan="1" colspan="1">50.2 (+0.4)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">yes</td><td rowspan="1" colspan="1">450</td><td rowspan="1" colspan="1">4.0</td></tr><tr><td rowspan="1" colspan="1">PG8</td><td rowspan="1" colspan="1">2&#x02032;F-ANA all-loop</td><td rowspan="1" colspan="1">d(GG<bold>TT</bold>GG<bold>TGT</bold>GG<bold>TT</bold>GG)</td><td rowspan="1" colspan="1">56.3 (+1.3)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">280</td><td rowspan="1" colspan="1">5.9</td></tr><tr><td rowspan="1" colspan="1">PG9</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GG<bold>TT</bold>GG<bold>T</bold>G<bold>T</bold>GG<bold>TT</bold>GG)</td><td rowspan="1" colspan="1">57.1 (+1.6)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">2.8</td></tr><tr><td rowspan="1" colspan="1">PG10</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GGT<bold>T</bold>GG<bold>T</bold>G<bold>T</bold>GG<bold>TT</bold>GG)</td><td rowspan="1" colspan="1">51.2 (+0.8)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">250</td><td rowspan="1" colspan="1">2.7</td></tr><tr><td rowspan="1" colspan="1">PG11</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GG<bold>TT</bold>GG<bold>T</bold>G<bold>T</bold>GG<bold>T</bold>TGG)</td><td rowspan="1" colspan="1">56.6 (+1.8)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">370</td><td rowspan="1" colspan="1">5.1</td></tr><tr><td rowspan="1" colspan="1">PG12</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GG<bold>TT</bold>GGTGTGG<bold>TT</bold>GG)</td><td rowspan="1" colspan="1">59.1 (+2.9)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">310</td><td rowspan="1" colspan="1">3.5</td></tr><tr><td rowspan="1" colspan="1">PG13</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GGTTGG<bold>T</bold>G<bold>T</bold>GG<bold>TT</bold>GG)</td><td rowspan="1" colspan="1">51.0 (+0.9)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">58</td><td rowspan="1" colspan="1">3.4</td></tr><tr><td rowspan="1" colspan="1">PG14</td><td rowspan="1" colspan="1">2&#x02032;F-ANA loop</td><td rowspan="1" colspan="1">d(GG<bold>TT</bold>GG<bold>T</bold>G<bold>T</bold>GGTTGG)</td><td rowspan="1" colspan="1">50.6 (+0.8)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">no</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">2.0</td></tr><tr><td rowspan="1" colspan="1">P8</td><td rowspan="1" colspan="1">ssDNA control</td><td rowspan="1" colspan="1">d(GTCTCTTGTGTGACTCTGGTAAC)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NC</td><td rowspan="1" colspan="1">0.5</td></tr><tr><td rowspan="1" colspan="1">H1</td><td rowspan="1" colspan="1">Hairpin control (RNA)</td><td rowspan="1" colspan="1">r(GGACUUCGGUCC)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NC</td><td rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><sup>a</sup>Capital and bold letter: <bold>2</bold>&#x02032;<bold>F-ANA</bold>.</p></fn><fn id="TF2"><p><sup>b</sup>&#x00394;<italic>T</italic><sub>m</sub> is the <italic>T</italic><sub>m</sub> change per each 2&#x02032;F-ANA residue between any modified aptamer with the unmodified DNA aptamer (PG1, <italic>T</italic><sub>m</sub> = 47.4&#x000b0;C); NA: not applicable.</p></fn><fn id="TF3"><p><sup>c</sup>&#x02018;Type I&#x02019; CD spectrum refers to a positive CD band at &#x0223c;265&#x02009;nm and a negative band at &#x0223c;240&#x02009;nm that correlates with G-anti conformation in the G-quartet. &#x02018;Type II&#x02019; CD refers to a CD spectrum with positive band at &#x0223c;295&#x02009;nm and a negative band at &#x0223c;260&#x02009;nm, which indicates a mixed <italic>anti</italic>-G and <italic>syn-</italic>G conformation in the G-quartet. CD was measured in the buffer of 10&#x02009;mM Tris, pH 6.8, 25&#x02009;mM KCl (<xref ref-type="bibr" rid="B12">12</xref>).</p></fn><fn id="TF4"><p><sup>d</sup>Hysterisis in <italic>T</italic><sub>m</sub> refers to the hysterisis existing between a heating and cooling process with 0.5&#x000b0;C/min temperature change during <italic>T</italic><sub>m</sub> measurements.</p></fn><fn id="TF5"><p><sup>e</sup><italic>K</italic><sub>d</sub> was roughly estimated from the concentration (nM) where 50% of the maximum binding percentage was observed with a certain aptamer during the thrombin concentrations studied; NC: not calculated.</p></fn><fn id="TF6"><p><sup>f</sup>Half-life in 10% fetal bovine serum (FBS) as monitored by 20% polyacrylamide gel electrophoresis.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="T2" position="float"><label>Table 2.</label><caption><p>CD and <italic>T</italic><sub>m</sub> data of d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) and d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) and related oligonucleotides</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Code</th><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Sequence<xref ref-type="table-fn" rid="TF7"><sup>a</sup></xref></th><th rowspan="1" colspan="1">CD Type<xref ref-type="table-fn" rid="TF8"><sup>b</sup></xref><xref ref-type="table-fn" rid="TF9"><sup>,c</sup></xref></th><th rowspan="1" colspan="1"><italic>T</italic><sub>m</sub><xref ref-type="table-fn" rid="TF10"><sup>d</sup></xref> (&#x00394;<italic>T</italic><sub>m</sub>)<xref ref-type="table-fn" rid="TF11"><sup>e</sup></xref> (&#x000b0;C)</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) and related sequences</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PG17</td><td rowspan="1" colspan="1">All PO-DNA</td><td rowspan="1" colspan="1">PO-d(TTGGGGTT)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">66.0</td></tr><tr><td rowspan="1" colspan="1">PG18</td><td rowspan="1" colspan="1">All PS-DNA</td><td rowspan="1" colspan="1">PS-d(TTGGGGTT)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">73.5<sup>(43)</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">74.0</td></tr><tr><td rowspan="1" colspan="1">PG19</td><td rowspan="1" colspan="1">All PS-2&#x02032;F-ANA</td><td rowspan="1" colspan="1">PS-d(<bold>TTGGGGTT</bold>)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">83.0 (+1.1)</td></tr><tr><td rowspan="1" colspan="1">PG20</td><td rowspan="1" colspan="1">PS-2&#x02032;F-ANA-G</td><td rowspan="1" colspan="1">PS-d(TT<bold>GGGG</bold>TT)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">87.0 (+3.3)</td></tr><tr><td rowspan="1" colspan="1"><italic>d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) and related sequences</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PG21</td><td rowspan="1" colspan="1">All PO-DNA</td><td rowspan="1" colspan="1">PO-d(GGGGTTTTGGGG)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">65<sup>(44)</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">64.4</td></tr><tr><td rowspan="1" colspan="1">PG22</td><td rowspan="1" colspan="1">All PO-2&#x02032;F-ANA</td><td rowspan="1" colspan="1">PO-d(<bold>GGGGTTTTGGGG</bold>)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">90.0 (+2.1)</td></tr><tr><td rowspan="1" colspan="1">PG23</td><td rowspan="1" colspan="1">G-<italic>syn</italic></td><td rowspan="1" colspan="1">PO-d(<bold>G</bold>G<bold>G</bold>GTTTT<bold>G</bold>G<bold>G</bold>G)</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">72.5 (+2.0)</td></tr><tr><td rowspan="1" colspan="1">PG24</td><td rowspan="1" colspan="1">G-<italic>anti</italic></td><td rowspan="1" colspan="1">PO-d(G<bold>G</bold>G<bold>G</bold>TTTTG<bold>G</bold>G<bold>G</bold>)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">66.2 (+0.5)</td></tr></tbody></table><table-wrap-foot><fn id="TF7"><p><sup>a</sup>Capital and bold letter: <bold>2&#x02032;F-ANA</bold>; PO: phosphate linkage; PS: phosphorothioate linkage.</p></fn><fn id="TF8"><p><sup>b</sup>CD type I &#x00026; II refer to the note in <xref ref-type="table" rid="T1">Table 1</xref>.</p></fn><fn id="TF9"><p><sup>c</sup>dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20): phosphate-buffered saline (PBS buffer, pH 7.2 at 25&#x000b0;C), 137&#x02009;mM NaCl, 2.7&#x02009;mM KCl, 1.5&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 8&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub>; strand concentration: 20&#x02009;&#x000b5;M for both CD and <italic>T</italic><sub>m</sub> experiments. dG<sub>4</sub>T<sub>4</sub>G<sub>4</sub> and related sequences (PG21&#x02013;24): 10&#x02009;mM sodium phosphate buffer, 0.1&#x02009;mM EDTA, pH 7 and 200&#x02009;mM NaCl; strand concentration: 10&#x02009;&#x000b5;M.</p></fn><fn id="TF10"><p><sup>d</sup>dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20): phosphate-buffered saline (PBS buffer, pH 7.2 at 25&#x000b0;C), 137&#x02009;mM NaCl, 2.7&#x02009;mM KCl, 1.5&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 8&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub>; strand concentration: 20&#x02009;&#x000b5;M; <italic>T</italic><sub>m</sub> data were generated from concentration-dependent CD spectra (Figure S5 and &#x02018;Materials and methods&#x02019; section). dG<sub>4</sub>T<sub>4</sub>G<sub>4</sub> and related sequences (PG21&#x02013;24): 10&#x02009;mM sodium phosphate buffer, 0.1&#x02009;mM EDTA, pH 7 and 200&#x02009;mM NaCl; strand concentration: 100&#x02009;&#x000b5;M; <italic>T</italic><sub>m</sub> measurements were conducted at 295&#x02009;nm wavelength.</p></fn><fn id="TF11"><p><sup>e</sup>&#x00394;<italic>T</italic><sub>m</sub> (&#x000b0;C) is the <italic>T</italic><sub>m</sub> change/2&#x02032;F-ANA modification of PG18&#x02013;20 or PG22&#x02013;24 relative to the control PG18 (74.0&#x000b0;C) or PG21 (PG64.4&#x000b0;C), respectively.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>UV thermal melting studies (<italic>T</italic><sub>m</sub>)</title><p>UV thermal dissociation data was obtained on a Varian CARY 1 spectrophotometer equipped with a Peltier temperature controller. Thrombin-binding aptamers (PG1&#x02013;14) were dissolved in <italic>T</italic><sub>m</sub> buffer (10&#x02009;mM Tris, pH 6.8, with and without 25&#x02009;mM KCl) at a final concentration of 8&#x02009;&#x003bc;M (<xref ref-type="bibr" rid="B42">42</xref>). Thrombin-binding aptamers were annealed in <italic>T</italic><sub>m</sub> buffer at 80&#x000b0;C for 10&#x02009;min, allowed to cool to room temperature and refrigerated (4&#x000b0;C) overnight before measurements. dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20) were dissolved in phosphate-buffered saline (PBS buffer, pH 7.2) composed of 137&#x02009;mM NaCl, 2.7&#x02009;mM KCl, 1.5&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 8&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub> at a final concentration of 20&#x02009;&#x000b5;M (<xref ref-type="bibr" rid="B43">43</xref>). The telomeric DNA dG<sub>4</sub>T<sub>4</sub>G<sub>4</sub> and related sequences (PG21&#x02013;24) were dissolved in 10&#x02009;mM sodium phosphate buffer (pH 7, 0.1&#x02009;mM EDTA and 200&#x02009;mM NaCl) at a final concentration of 100&#x02009;&#x000b5;M (<xref ref-type="bibr" rid="B44">44</xref>). All samples (PG17&#x02013;24) were annealed at 98&#x000b0;C for 5&#x02009;min, naturally cooled down to room temperature and refrigerated (4&#x000b0;C) overnight before measurements. The annealed samples were transferred to pre-chilled Hellma QS-1.000 (Cat #114) quartz cell, sealed with a Teflon-wrapped stopper and degassed by placing them in an ultrasonic bath for 1&#x02009;min. Extinction coefficients were obtained from the following internet site (<ext-link ext-link-type="uri" xlink:href="http://www.idtdna.com/analyzer/applications/oligoanalyzer">http://www.idtdna.com/analyzer/applications/oligoanalyzer</ext-link>) based on the nearest-neighbor approach (<xref ref-type="bibr" rid="B45">45</xref>) and modified aptamers (phosphorothioates and 2&#x02032;F-ANA) were assumed to have the same extinction coefficient as the natural DNA aptamer. Denaturation/cooling curves were acquired at either at 295&#x02009;nm for d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>) and related sequences (PG1&#x02013;14), dG<sub>4</sub>T<sub>4</sub>G<sub>4</sub> and related sequences (PG21&#x02013;24), or at 260&#x02009;nm for dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20), at a heating/cooling rate of 0.5&#x000b0;C/min between 10 and 80&#x000b0;C (for PG1&#x02013;14), 20 and 90&#x000b0;C (for PG17&#x02013;20) or 40 and 98&#x000b0;C (for PG21&#x02013;24). The data were analyzed with the software provided by Varian and converted to Microsoft Excel (<xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>). The decreases in UV absorbance (hypochromicity) with increasing temperature were normalized between 1 and 0 by the formula: <italic>N</italic> = (<italic>A</italic><sub>t</sub> &#x02212; <italic>A</italic><sub>l</sub>)/(<italic>A</italic><sub>h</sub> &#x02212; <italic>A</italic><sub>l</sub>), where <italic>A</italic><sub>t</sub> is the absorbance at any given temperature (<italic>t</italic>), <italic>A</italic><sub>l</sub> is the minimum absorbance reading at high temperature and <italic>A</italic><sub>h</sub> is the maximum absorbance reading at low temperature. <italic>T</italic><sub>m</sub> concentration dependence studies were also conducted in the same way at 295&#x02009;nm using thrombin-binding aptamers (PG1&#x02013;14) with different concentrations ranging from 4 to 76&#x02009;&#x003bc;M. Starna quartz cells (Starna Cells, Inc., Cat. # 1-Q-1) with 1-mm path length were used at high concentrations to reduce the amount of aptamers required and to avoid exceeding the Absorbance range of the instrument.</p></sec><sec><title>Circular dichroism (CD) spectra</title><p>CD spectra (200&#x02013;320&#x02009;nm) were collected on a Jasco J-710 spectropolarimeter at a rate of 100&#x02009;nm/min using fused quartz cells (Hellma, 165-QS). Measurements were carried out either in 10&#x02009;mM Tris, pH 6.8 (with and without 25&#x02009;mM KCl) at a concentration of 8&#x02009;&#x003bc;M for thrombin-binding aptamers (PG1&#x02013;14) (<xref ref-type="bibr" rid="B42">42</xref>); in PBS buffer (pH 7.2, 137&#x02009;mM NaCl, 2.7&#x02009;mM KCl, 1.5&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 8&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub>) for dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20) at a final concentration of 20&#x02009;&#x000b5;M (<xref ref-type="bibr" rid="B43">43</xref>), or in sodium phosphate buffer (10&#x02009;mM sodium phosphate buffer, pH 7, 0.1&#x02009;mM EDTA and 200&#x02009;mM NaCl) for dG<sub>4</sub>T<sub>4</sub>G<sub>4</sub> and related sequences (PG21&#x02013;24) at a final concentration of 100&#x02009;&#x000b5;M (<xref ref-type="bibr" rid="B44">44</xref>). Temperature was controlled by an internal circulating bath (VWR Scientific) at constant temperature. The data was processed using J-700 Windows software supplied by the manufacturer (JASCO, Inc.). To facilitate comparisons, the CD spectra were background subtracted, smoothed and corrected for concentration so that molar ellipticities could be obtained. Temperature-dependent CD spectra were also conducted for dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20). A 10-min equilibration time was allowed at each temperature before CD scanning. The <italic>T</italic><sub>m</sub> profile was obtained by plotting the maximum molar ellipticities versus temperature and normalizing.</p></sec><sec><title>Nuclease stability assay</title><p>Nuclease stability of anti-thrombin aptamers was conducted in 10% fetal bovine serum (FBS, Wisent Inc., Cat. #080150) diluted with multicell Dulbecco's Modified Eagle's Medium (DMEM, Wisent Inc., Cat. #319005-CL) at 37&#x000b0;C. A single-strand DNA (ssDNA) 23mer (P-8), which is unable to form G-quadruplexes, was used as a control. Approximately 8&#x02009;&#x003bc;mol of stock solution of aptamers and ssDNA control (&#x0223c;1.2 O.D.U) was evaporated to dryness under reduced pressure and then incubated with 300&#x02009;&#x003bc;l 10% FBS at 37&#x000b0;C. At 0, 0.25, 0.5, 1, 2, 6 and 24&#x02009;h, 50&#x02009;&#x003bc;l of samples were collected and stored at &#x02013;20&#x000b0;C for at least 20&#x02009;min. The samples were evaporated to dryness and then 10&#x02009;&#x003bc;l of gel loading buffer and 10&#x02009;&#x003bc;l of autoclaved water was added. 10&#x02009;&#x003bc;l of the mixture was used for polyacrylamide gel electrophoresis (PAGE), which was carried out at room temperature using 20% polyacrylamide gel in 0.5&#x000d7; TBE buffer (Tris-borate-EDTA). The degradation patterns on the gels were visualized using Stains-All (Bio-Rad) according to the manufacturer's protocol.</p></sec><sec><title>5&#x02032;-End labeling of synthetic oligonucleotides</title><p>Aptamers (PG1&#x02013;14) were radiolabeled at the 5&#x02032;-hydroxyl terminus with a radioactive <sup>32</sup>P probe using a T4 polynucleotide kinase (T4 PNK) according to the manufacture's specifications (MBI Fermentas Life Sciences, Burlington, ON). Incorporation of the <sup>32</sup>P label was accomplished in reaction mixtures consisting of DNA aptamers substrate (100&#x02009;pmol), 2&#x02009;&#x003bc;l 10 &#x000d7; reaction buffer (500&#x02009;mM Tris&#x02013;HCl, pH 7.6 at 25&#x000b0;C, 100&#x02009;mM MgCl<sub>2</sub>, 50&#x02009;mM DTT, 1&#x02009;mM spermidine and 1&#x02009;mM EDTA), 1&#x02009;&#x003bc;l T4 PNK enzyme solution (10&#x02009;U/1&#x003bc;l in a solution of 20&#x02009;mM Tris&#x02013;HCl, pH 7.5, 25&#x02009;mM KCl, 0.1&#x02009;mM EDTA, 2&#x02009;mM DTT and 50% glycerol), 6&#x02009;&#x003bc;l [&#x003b3;-<sup>32</sup>P]-ATP solution (6000&#x02009;Ci/mmol, 10&#x02009;mCi/ml; Amersham Biosciences, Inc.) and autoclaved sterile water to a final volume of 20&#x02009;&#x003bc;l. The reaction mixture was incubated for 30&#x02013;45&#x02009;min at 37&#x000b0;C, followed by a second incubation for 5&#x02009;min at 95&#x000b0;C to thermally denature and deactivate the kinase enzyme. The solution was purified according to a standard protocol (<xref ref-type="bibr" rid="B46">46</xref>) and the isolated yield of <sup>32</sup>P-5&#x02032;-DNA following gel extraction averaged 50%. The pure labeled samples were kept at &#x02013;20&#x000b0;C for future use.</p></sec><sec><title>Nitrocellulose filter binding assay</title><p>Labeled aptamers (1.25&#x02009;pmol) were heated to 95&#x000b0;C for 5&#x02009;min in the binding buffer (Tris&#x02013;Ac, pH 7.4, 140&#x02009;mM NaCl, 5&#x02009;mM KCl, 1&#x02009;mM CaCl<sub>2</sub>, 1&#x02009;mM MgCl<sub>2</sub>) (<xref ref-type="bibr" rid="B6">6</xref>) and immediately placed on ice for 5&#x02009;min before binding to increasing concentrations of thrombin protease (Amersham Biosciences, Inc.) ranging from 10 to 1000&#x02009;nM in the binding buffer at 37&#x000b0;C in a final volume of 20&#x02009;&#x003bc;l for 30&#x02009;min. Mixtures were filtered through a nitrocellulose filter (13&#x02009;mm Millipore, HAWP, 0.45&#x02009;&#x003bc;m) pre-wetted with binding buffer in a Millipore filter binding apparatus, and immediately rinsed with 600&#x02009;&#x003bc;l ice-cold washing buffer [Tris&#x02013;Ac, pH 7.4, 140&#x02009;mM NaCl, 5&#x02009;mM KCl, 1&#x02009;mM CaCl<sub>2</sub>, 1&#x02009;mM MgCl<sub>2</sub>, 1% sodium pyrophosphate (w/v)], then the filter was air-dried and the bound aptamer quantified by scintillation counting. The binding percentage (%) was calculated by the subtraction of the background from the counts in the microtube. <italic>K</italic><sub>d</sub> was roughly estimated from the concentration (nM) where 50% of the maximum binding percentage was observed with a certain aptamer during the thrombin concentrations studied.</p></sec></sec><sec><title>RESULTS AND DISCUSSION</title><p>Oligonucleotide aptamers derived from SELEX have drawn great attention for their potential as therapeutic and diagnostic agents (<xref ref-type="bibr" rid="B47 B48 B49 B50">47&#x02013;50</xref>). The application of nucleic acid aptamers <italic>in vivo</italic> and their possible use in pharmacotherapy face the same key hurdles as siRNA and antisense based therapeutics, e.g. delivery, cellular uptake and biostability. To date, several methods have been devised to improve the stability of aptamers, most of which make use of SELEX, including a mirror-design of RNA aptamers (or &#x02018;Spiegelmers&#x02019;) (<xref ref-type="bibr" rid="B51">51</xref>); post-SELEX modification by 2&#x02032;-OMe to increase the stabilization of RNA aptamers (<xref ref-type="bibr" rid="B32">32</xref>); and direct evolution in SELEX using modified dNTPs or rNTPs (e.g. 2&#x02032;-F, 2&#x02032;-NH<sub>2</sub> pyrimidine 5&#x02032;-triphosphate) (<xref ref-type="bibr" rid="B52 B53 B54 B55 B56">52&#x02013;56</xref>). Macugen&#x000ae;, an aptamer recently approved by the FDA for the treatment of neovascular age-related macular degeneration, is a 2&#x02032;F/2&#x02032;-OMe ribose-modified oligomer (<xref ref-type="bibr" rid="B57">57</xref>). There still exists a great demand for new methods and more diverse range of chemistries to create aptamers with more favorable pharmacokinetic properties.</p><sec><title>A fully 2&#x02032;F-ANA modified thrombin-binding aptamer</title><p>The study began with the replacement of all the deoxynucleotides in the thrombin-binding aptamer d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>) by 2&#x02032;F-ANA units. Consistent with literature results (<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B42">42</xref>), it was found through comparisons of the <italic>T</italic><sub>m</sub> profiles both with and without the presence of K<sup>+</sup>, that potassium ions stabilized the unimolecular G-quadruplex of the DNA aptamer (PG1) (<xref ref-type="fig" rid="F2">Figure 2</xref>A and B). As shown in the literature, similar hypochromicity (UV absorbance decrease with increased temperature) was observed at 295&#x02009;nm for all DNA sequence (<xref ref-type="bibr" rid="B42">42</xref>), which is an indication of G-quartet formation (<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B58">58</xref>). The <italic>T</italic><sub>m</sub> of the all DNA aptamer obtained in this study was 47.4&#x000b0;C (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F2">Figure 2</xref>B), consistent with 46.4&#x000b0;C reported by Smirnov and Shafe (<xref ref-type="bibr" rid="B42">42</xref>) and the CD spectra also support the UV melting experiment. Previous studies have shown two typical CD spectra: a CD spectrum with a positive CD band at &#x0223c;265&#x02009;nm and a negative band at &#x0223c;240&#x02009;nm (Type I CD spectrum) is related to a parallel quadruplex with all <italic>anti</italic>-Gs, while one with a positive band at &#x0223c;295&#x02009;nm and a negative band at &#x0223c;260&#x02009;nm (Type II CD spectrum) corresponds to antiparallel quadruplex with alternating <italic>syn-anti</italic> Gs (<xref ref-type="bibr" rid="B12">12</xref>). The all DNA aptamer shows very low amplitude bands without K<sup>+</sup>, whereas it demonstrates characteristic Type II CD when K<sup>+</sup> is present, indicating a G-quadruplex structure with alternating <italic>syn-anti</italic> Gs (<xref ref-type="fig" rid="F2">Figure 2</xref>C and D) (<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>). The lack of concentration dependence in the <italic>T</italic><sub>m</sub> data (<xref ref-type="fig" rid="F3">Figure 3</xref>) and the lack of hysteresis in the heating/cooling processes (<xref ref-type="fig" rid="F4">Figure 4</xref>) support a unimolecular G-quadruplex structure (<xref ref-type="fig" rid="F1">Figure 1</xref>B). Lack of hysteresis at a heating/cooling rate of 0.5&#x000b0;C/min indicates a fast kinetics for the formation of unimolecular quadruplexes (<xref ref-type="bibr" rid="B58">58</xref>).
<fig id="F2" position="float"><label>Figure 2.</label><caption><p><italic>T</italic><sub>m</sub> profiles of selected 2&#x02032;F-ANA-modified thrombin-binding aptamers (<xref ref-type="table" rid="T1">Table 1</xref>) measured at 295&#x02009;nm in buffer 10&#x02009;mM Tris, pH 6.8 (<bold>A</bold>) without KCl; (<bold>B</bold>) with 25&#x02009;mM KCl, at a final strand concentration of 8&#x02009;&#x003bc;M. The <italic>T</italic><sub>m</sub> data are provided in <xref ref-type="table" rid="T1">Table 1</xref>. CD spectra in the same buffer consisting of 10&#x02009;mM Tris, pH 6.8 (<bold>C</bold>) without KCl; (<bold>D</bold>) with 25&#x02009;mM KCl at 15&#x000b0;C at a final strand concentration of 8&#x02009;&#x003bc;M. Type I and Type II CD types are shown in (<bold>D</bold>).</p></caption><graphic xlink:href="gkm520f2"/></fig>
<fig id="F3" position="float"><label>Figure 3.</label><caption><p><italic>T</italic><sub>m</sub> versus concentration dependence (15&#x02013;20-folds) study measured at 295&#x02009;nm in a buffer consisting of 10&#x02009;mM Tris, pH 6.8, 25&#x02009;mM KCl for selected 2&#x02032;F-ANA modified thrombin-binding aptamers (<xref ref-type="table" rid="T1">Table 1</xref>).</p></caption><graphic xlink:href="gkm520f3"/></fig>
<fig id="F4" position="float"><label>Figure 4.</label><caption><p>Heating and cooling <italic>T</italic><sub>m</sub> transitions of 2&#x02032;F-ANA modified thrombin-binding aptamers (<xref ref-type="table" rid="T1">Table 1</xref>) measured at 295&#x02009;nm in a buffer of 10&#x02009;mM Tris, 25&#x02009;mM KCl, pH 6.8, at a final strand concentration of 8 &#x003bc;M in a heating/cooling rate of 0.5&#x000b0;C/min (red filled square: heating; blue empty square: cooling).</p></caption><graphic xlink:href="gkm520f4"/></fig></p><p>The all 2&#x02032;F-ANA aptamer (PG2) also forms a defined G-quadruplex stabilized by K<sup>+</sup> in the UV melting experiment (<xref ref-type="fig" rid="F2">Figure 2</xref>A and B). The G-quadruplex of all 2&#x02032;F-ANA aptamer (PG2) is more thermally stable than the all DNA aptamer (PG1) (&#x00394;<italic>T</italic><sub>m</sub> = 0.4&#x000b0;C/2&#x02032;F-ANA modification in <xref ref-type="table" rid="T1">Table 1</xref>). Further characterization experiments indicated that the G-quadruplex PG2 formed in K<sup>+</sup> is different from that of that of PG1. The effect of K<sup>+</sup> on the CD spectra is consistent with the <italic>T</italic><sub>m</sub> experiment: very low absorbance in the absence of K<sup>+</sup> and a strong positive absorbance peak at 260&#x02009;nm in the presence of K<sup>+</sup>. Clearly this CD spectrum is Type I, which corresponds to a parallel quadruplex with all <italic>anti</italic>-Gs (<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>). A concentration-dependent <italic>T</italic><sub>m</sub> profile indicates the existence of intermolecular G-quadruplex formation (<xref ref-type="fig" rid="F3">Figure 3</xref>). Even though we could not tell the existence of a dimeric or tetrameric G-quadruplex with all parallel strand alignments, it is clearly shown that all 2&#x02032;F-ANA aptamer (PG2) could not maintain the unimolecular G-quadruplex topology (<xref ref-type="fig" rid="F1">Figure 1</xref>B). An intermolecular G-quadruplex is thus formed to support a G-quartet structure with all <italic>anti</italic>-Gs. Hysteresis was observed in the heating and cooling processes, again supporting an intermolecular G-quadruplex adopted by PG2 (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p></sec><sec><title>Replacement of <italic>anti</italic>-Gs and <italic>syn</italic>-Gs with 2&#x02032;F-ANA</title><p>Nucleotides with preferred glycosidic conformations have been utilized to investigate their effect on the topology and molecularity of G-tetrads. For example, 8-methyldeoxyguanosine (8-Me-dG) and 8-bromodeoxyguanosine (8-Br-dG) which prefer <italic>syn</italic> conformation have demonstrated to play an important role in G-quadruplex conformation and thermal stability when they are used to modify a tetrameric G-quadruplex [d(TGGGT)]<sub>4</sub> (<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>). Recent studies by Tang and Shafer (<xref ref-type="bibr" rid="B61">61</xref>) demonstrate that ribonucleic acids which favor an <italic>anti</italic> conformation provide enough driving force to change the topology and molecularity for the thrombin-binding aptamer d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>). A single locked nucleic acid (LNA) modification in an expected antiparallel folded quadruplex d(G<sub>4</sub>(T<sub>4</sub>G<sub>4</sub>)<sub>3</sub>) has also been shown to induce a significant topological change to a parallel quadruplex in the presence of K<sup>+</sup> (<xref ref-type="bibr" rid="B62">62</xref>). 2&#x02032;F-ANA unit which has been shown to have a conformationally biased sugar pucker (<xref ref-type="bibr" rid="B33">33</xref>) (i.e. more <italic>south/east</italic> than its DNA counterpart), is expected to favor an <italic>anti</italic> conformation in order to avoid steric interaction between guanine and the &#x003b2;-face fluorine (<xref ref-type="bibr" rid="B63">63</xref>) (<xref ref-type="fig" rid="F5">Figure 5</xref>). Therefore, the next phase of the investigation was to study the effect of 2&#x02032;F-araG on <italic>anti</italic>-Gs and <italic>syn</italic>-Gs observed in the different G-quadruplexes discussed earlier (see &#x02018;Introduction&#x02019; section). We expected that the replacement of <italic>anti</italic>-Gs with 2&#x02032;F-ANA would lead to thermal stabilization since preorganization of the <italic>anti</italic> glycosidic conformation favored by 2&#x02032;F-araG (<xref ref-type="bibr" rid="B63">63</xref>) would reduce the loss of entropy during G-quartet assembly. Conversely, replacement of <italic>syn</italic>-Gs with 2&#x02032;F-araGs is expected to cause destabilization or complete disruption of the G-quartet structure altogether.
<fig id="F5" position="float"><label>Figure 5.</label><caption><p>Glycosic conformation equilibrium of dG and 2&#x02032;F-araG with south furanose sugar ring.</p></caption><graphic xlink:href="gkm520f5"/></fig></p><p>The obtained <italic>T</italic><sub>m</sub> and CD data are consistent with the expected results. Modifying the <italic>anti</italic>-Gs with 2&#x02032;F-ANA (PG3) or modifying both the <italic>anti</italic>-Gs and the loops with 2&#x02032;F-ANA (PG4) increases thermal stability in the presence of K<sup>+</sup> (&#x00394;<italic>T</italic><sub>m</sub> = +1.3&#x02013;1.5&#x000b0;C/2&#x02032;F-ANA modification). The CD spectrum of PG3 was Type I CD, similar to the all DNA aptamer (PG1) (<xref ref-type="fig" rid="F2">Figure 2</xref>C and D). Remarkably, PG4 shows a clear Type I CD both without and with K<sup>+</sup>, demonstrating that the G-quadruplex adopted by PG4 could form even in the absence of K<sup>+</sup>. In addition, it suggests that replacement of the loop with 2&#x02032;F-ANA further benefits the G-quadruplex formation. This is consistent with previous work showing that all the thymidines in this thrombin-binding DNA aptamer adopt the <italic>anti</italic> orientation (<xref ref-type="bibr" rid="B15">15</xref>). A concentration-independent <italic>T</italic><sub>m</sub> profile (<xref ref-type="fig" rid="F3">Figure 3</xref>) and lack of hysteresis in heating/cooling processes both support a unimolecular G-quadruplex structure like the DNA control (<xref ref-type="fig" rid="F4">Figure 4</xref> and Figure S1 in Supplementary Data). Replacement of <italic>anti</italic>-G with 2&#x02032;F-ANA is therefore able to stabilize the G-quartet without changing the quadruplex topology.</p><p>The results of replacement of the <italic>syn</italic>-Gs with 2&#x02032;F-ANA also match expectations. Modification of the <italic>syn</italic>-Gs with 2&#x02032;F-ANA (PG5) and replacement of both <italic>syn</italic>-Gs and loops (PG6) with 2&#x02032;F-ANA result in less stable complexes compared with PG3 and PG4. PG5 is even less stable than the original all DNA aptamer (&#x00394;<italic>T</italic><sub>m</sub> = &#x02013;0.5&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Table 1</xref>), and PG6 is only as stable as the all DNA aptamer control (&#x00394;<italic>T</italic><sub>m</sub> = +0.1&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Table 1</xref>). CD experiments show that both PG5 and PG6 display very low amplitude peaks at 260&#x02009;nm even in the presence of K<sup>+</sup>, indicating little structure formed (<xref ref-type="fig" rid="F2">Figure 2</xref>C and D and Figure S4 in Supplementary Data). A <italic>T</italic><sub>m</sub> versus concentration study suggested that the <italic>T</italic><sub>m</sub> of PG5 and PG6 is independent of concentration so they likely still form unimolecular structures (<xref ref-type="fig" rid="F3">Figure 3</xref>) but the formation of these structures seems kinetically slow based on the finding that major hysteresis is observed at a heating/cooling rate of 0.5&#x000b0;C/min (<xref ref-type="fig" rid="F4">Figure 4</xref> and Figure S1 in Supplementary Data). Taken together, if the unimolecular G-quadruplex is maintained in PG5 and PG6, the folding topology should be changed to tolerate a unimolecular all-parallel G-quadruplex structure with all <italic>anti</italic>-Gs indicated by a Type I CD profile. A parallel unimolecular quadruplex has been demonstrated in an X-ray crystal structure of the human telomere sequence d(AG<sub>3</sub>(TTAG<sub>3</sub>)<sub>3</sub>) by Neidle and coworkers (<xref ref-type="bibr" rid="B64">64</xref>) and in a LNA modified d(G<sub>4</sub>(T<sub>4</sub>G<sub>4</sub>)<sub>3</sub>) quadruplex by Dominick and Jarstfer (<xref ref-type="bibr" rid="B62">62</xref>). It seems that this atypical folding in PG5 and PG6 is not favored since the defined structure is not present in significant quantity in solution, as indicated by the previous CD experiments. The possible reason could be the loop size and sequences which are important factors in determining the folding topology (<xref ref-type="bibr" rid="B64">64</xref>). Furthermore, in the case where 2&#x02032;F-araGs replace both <italic>syn</italic>-Gs and <italic>anti</italic>-Gs in the quartet (PG7), we found that 2&#x02032;F-ANA brings minimal stabilization (&#x00394;<italic>T</italic><sub>m</sub> = +0.4&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Table 1</xref>). Type I CD profile (i.e. a positive CD band at &#x0223c;260&#x02009;nm and a negative band at &#x0223c;240&#x02009;nm) was observed in the presence of K<sup>+</sup> and not shown in the absence of K<sup>+</sup>, indicating a parallel quadruplex with all <italic>anti</italic>-Gs (<xref ref-type="bibr" rid="B12">12</xref>), as in PG2. Concentration-dependent <italic>T</italic><sub>m</sub> (<xref ref-type="fig" rid="F3">Figure 3</xref>) and significant hysteresis observed in heating/cooling processes (<xref ref-type="fig" rid="F4">Figure 4</xref>) support the idea that PG7 could adopt an intermolecular parallel G-quadruplex with all <italic>anti</italic>-Gs. Further non-denaturing shift gel analysis experiments are needed to confirm the molecularity of intermolecular G-quadruplexes studied here.</p><p>To verify whether <italic>anti</italic>-Gs can be stabilized by 2&#x02032;F-ANA in other types of G-quadruplexes, we chose two other aptamers from the literature.</p><p>(A) <italic>Anti-HIV phosphorothioate PS-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) modified with 2</italic>&#x02032;<italic>F-ANA.</italic> Both the phosphodiester sequence PO-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) and the phosphorothioate sequence PS-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) are known to adopt a structure in which all G residues are in the <italic>anti</italic> conformation (<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B43">43</xref>). As a result, this aptamer has a characteristic &#x02018;Type I&#x02019; CD signature (<xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F6">Figure 6</xref>A) (<xref ref-type="bibr" rid="B12">12</xref>). Thermal denaturation studies at 260&#x02009;nm yielded noisy curves. The reason for this could be the slow dissociation process of both phosphodiester and phosphorothioate as reported in the literature (<xref ref-type="bibr" rid="B43">43</xref>). <italic>T</italic><sub>m</sub> profiles shown in <xref ref-type="fig" rid="F6">Figure 6</xref>B were obtained by plotting the maximum molar ellipticities versus temperature based on temperature-dependent CD spectra (Figure S5, Supplementary Data). Although it is impossible to get accurate <italic>T</italic><sub>m</sub> data for these kinetically slow G-quadruplexes, clearly our apparent <italic>T</italic><sub>m</sub> data help to confirm the significant thermal stabilization provided by the 2&#x02032;F-ANA-G units (PG18&#x02013;20, <xref ref-type="table" rid="T2">Table 2</xref>). Our results indicate that phosphorothioate modifications lead to stabilization, inconsistent with the literature finding (<xref ref-type="bibr" rid="B31">31</xref>). Compared with the controls PG17 (PO-DNA) and PG18 (PS-DNA), 2&#x02032;F-ANA modified sequences PG19 and PG20 show large increases in molar ellipticities, indicating a better guanine&#x02013;guanine interactions within the G-quartet structure.
<fig id="F6" position="float"><label>Figure 6.</label><caption><p>(<bold>A</bold>) CD spectra of dT<sub>2</sub>G<sub>4</sub>T<sub>2</sub> and related sequences (PG17&#x02013;20) obtained in PBS buffer at a strand concentration of 20&#x02009;&#x000b5;M (single strand). (<bold>B</bold>) <italic>T</italic><sub>m</sub> curves generated by plotting the maximum absorbance at 265&#x02009;nm wavelength (normalized) versus temperature in a series of CD-temperature-dependent measurements (Figure S5, Supplementary Data); the corresponding <italic>T</italic><sub>m</sub> data are shown in <xref ref-type="table" rid="T2">Table 2</xref>.</p></caption><graphic xlink:href="gkm520f6"/></fig></p><p>(B) <italic>A telomeric DNA d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) modified with 2</italic>&#x02032;<italic>F-ANA.</italic> Structural analysis has shown that a telomeric DNA sequence d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) (PG21, <xref ref-type="table" rid="T2">Table 2</xref>) can form a symmetrical dimeric quadruplex with four G-quartets and a diagonal loop in the presence of Na<sup>+</sup> (<xref ref-type="fig" rid="F1">Figure 1</xref>C) (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>). The guanine conformation is 5&#x02032;-d(G<italic><sub>s</sub></italic>G<italic><sub>a</sub></italic>G<italic><sub>s</sub></italic>G<italic><sub>a</sub></italic>-TTTT-G<italic><sub>s</sub></italic>G<italic><sub>a</sub></italic>G<italic><sub>s</sub></italic>G<italic><sub>a</sub></italic>)-3&#x02032; where <italic>s</italic> denotes <italic>syn</italic> and <italic>a anti</italic> (<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>). Several sequences, including a fully 2&#x02032;F-ANA modified sequence (PG22), a sequence with 2&#x02032;F-ANA replacing all <italic>syn</italic>-Gs (PG23) and a sequence with 2&#x02032;F-ANA modifications for all <italic>anti</italic>-Gs (PG24), were tested (<xref ref-type="table" rid="T2">Table 2</xref>). When the <italic>anti</italic>-G residues were replaced by 2&#x02032;F-ANA G residues, a modest thermal stabilization of the G-quadruplex structure resulted, without disruption of the 3D structure (<xref ref-type="table" rid="T2">Table 2</xref>, and <xref ref-type="fig" rid="F7">Figure 7</xref>A and B). When the <italic>syn</italic>-G residues were replaced (PG22 and PG23), a remarkable increase in thermal stabilization of the G-quadruplex structure resulted (up to 25&#x000b0;C; <xref ref-type="table" rid="T2">Table 2</xref>), with a concomitant Type II-to-Type I conformational change induced by the 2&#x02032;F-ANA-G(<italic>anti</italic>) replacement (<xref ref-type="fig" rid="F7">Figure 7</xref>A).
<fig id="F7" position="float"><label>Figure 7.</label><caption><p>(<bold>A</bold>) CD spectra of dT<sub>4</sub>G<sub>4</sub>T<sub>4</sub> and related sequences (PG21&#x02013;24) in 10&#x02009;mM sodium phosphate buffer, 0.1&#x02009;mM EDTA, pH 7 and 200&#x02009;mM NaCl at a strand concentration of 10&#x02009;&#x000b5;M. (<bold>B</bold>) <italic>T</italic><sub>m</sub> profile measured at 295&#x02009;nm in the same sodium phosphate buffer at a strand concentration of 100&#x02009;&#x000b5;M.</p></caption><graphic xlink:href="gkm520f7"/></fig></p><p>Overall, these two additional examples confirm the results obtained for the thrombin-binding aptamers: the modification of <italic>anti</italic>-Gs with 2&#x02032;F-ANA can generally stabilize a G-quartet requiring <italic>anti</italic>-Gs, maintaining the overall quadruplex conformation, while the modification of <italic>syn</italic>-Gs with 2&#x02032;F-ANA is not favored and results in a complete conformational switch to an alternative G-quadruplex structure, as indicated by the change of CD type from II to I for PG2, PG5, PG6, PG7, PG22 and PG23 (<xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="fig" rid="F2">Figure 2</xref>D, <xref ref-type="fig" rid="F7">Figure 7</xref>A and Figure S4 in Supplementary Data). The stabilizing effects of 2&#x02032;F-ANA on G-quadruplexes is related to the conformational preorganization and the small steric effect of the fluorine atom. 2&#x02032;-<italic>O</italic>-Methyl modification generates steric problems at the 2&#x02032; position and is often shown to destabilize a unimolecular G-quadruplex, resulting in significant conformational perturbation in both intra- and intermolecular G-quadruplex systems (<xref ref-type="bibr" rid="B31">31</xref>). The ability to switch G-quartet structures with a &#x003b2;-fluorine atom may be exploited to enrich the population of one of several interconverting G-quadruplex conformations (a &#x003b2;-fluorine &#x0201c;switch&#x0201d;).</p></sec><sec><title>Replacement of loops with 2&#x02032;F-ANA</title><p>Thymine bases in the loop region of the thrombin-binding aptamer d(G<sub>1</sub>G<sub>2</sub>T<sub>3</sub>T<sub>4</sub>G<sub>5</sub>G<sub>6</sub>T<sub>7</sub>G<sub>8</sub>T<sub>9</sub>G<sub>10</sub>G<sub>11</sub>T<sub>12</sub>T<sub>13</sub>G<sub>14</sub>G<sub>15</sub>) (<xref ref-type="fig" rid="F1">Figure 1</xref>B) exclusively prefers the <italic>anti</italic> orientation (<xref ref-type="bibr" rid="B15">15</xref>). The literature reports that G<sub>8</sub> shows base stacking interactions with the first G-quartet but the conformation of the nucleotide was not mentioned (<xref ref-type="bibr" rid="B18">18</xref>). The replacement of G<sub>8</sub> with 2&#x02032;F-araG in this study resulted in an increase of 0.8&#x000b0;C in <italic>T</italic><sub>m</sub> (PG8 and PG9 in <xref ref-type="table" rid="T1">Table 1</xref>). It was expected that the replacement of <italic>anti</italic> thymines in the loops with <italic>anti</italic> conformationally biased 2&#x02032;F-araT should increase thermal stability. Thermal melting studies support this hypothesis (PG8&#x02013;14, <xref ref-type="table" rid="T1">Table 1</xref>). Different positions of thymidine contribute to the stability of the G-quadruplex to different degrees (<xref ref-type="table" rid="T1">Table 1</xref> and Figure S2, Supplementary Data). 2&#x02032;F-ANA replacements in the loops consisting of two thymidines (PG12) bring a greater thermal stabilization (&#x00394;<italic>T</italic><sub>m</sub> = 2.9&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Table 1</xref>) than with modification in the TGT loop (PG9, &#x00394;<italic>T</italic><sub>m</sub> = 1.6&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Table 1</xref>). T<sub>3</sub> and T<sub>12</sub> are the most sensitive positions to 2&#x02032;F-araT modification resulting in an almost 6&#x000b0;C difference in <italic>T</italic><sub>m</sub> (PG9 versus PG10; PG11 versus PG14, <xref ref-type="table" rid="T2">Table 2</xref>), while the replacement of T<sub>13</sub> and T<sub>4</sub> with 2&#x02032;F-araT is much less sensitive and results only in slight <italic>T</italic><sub>m</sub> increases of 1&#x000b0;C (PG9 versus PG11, <xref ref-type="table" rid="T2">Table 2</xref>) and 0.2&#x000b0;C (PG10 versus PG13, <xref ref-type="table" rid="T2">Table 2</xref>), respectively. The crystal structure of this DNA aptamer bound to thrombin suggests that T<sub>3</sub> and T<sub>12</sub> are different from T<sub>4</sub> and T<sub>13</sub>. It appears that the bases of T<sub>3</sub> and T<sub>12</sub> do not interact with any other moieties within the aptamer, nor do they interact with thrombin, instead, they extend out into the solvent (<xref ref-type="bibr" rid="B18">18</xref>). Modifying T<sub>3</sub> and T<sub>12</sub> with 2&#x02032;F-araT might change the conformation of the loops, bringing out stabilization to the whole G-quadruplex structure as suggested by the <italic>T</italic><sub>m</sub> increase. A detailed picture, however, is difficult to describe at this stage. The replacement of the central nucleotide G<sub>8</sub> with a 2&#x02032;F-araG is also less important for stabilization (PG8 versus PG9, only 0.8&#x000b0;C <italic>T</italic><sub>m</sub> difference). Overall, 2&#x02032;F-ANA modifications of loop deoxynucleotides stabilizes the formation of a unimolecular G-quadruplex (<xref ref-type="fig" rid="F1">Figure 1</xref>B), as supported by all CD and UV melting analysis. It was found that all loop-modified thrombin-binding aptamers (PG8&#x02013;14) maintain Type II CD in the presence of K<sup>+</sup>, like the DNA aptamer control (Figure S4, Supplementary Data). Remarkably, in the absence of K<sup>+</sup>, a relatively strong positive peak at &#x0223c;295&#x02009;nm is still observed, which indicates significant G-quartet formation. Therefore, replacement of the loop deoxynucleotides with 2&#x02032;F-ANA significantly helps with the formation of G-quadruplex structure. They show concentration-independent <italic>T</italic><sub>m</sub> data, indicating a unimolecular structure, in agreement with a lack of hysteresis in heating/cooling processes (<xref ref-type="fig" rid="F4">Figure 4</xref> and Figure S1, Supplementary Data).</p></sec><sec><title>Nuclease resistance induced by 2&#x02032;F-ANA</title><p>Incorporation of 2&#x02032;F-ANA in oligonucleotides leads to an improvement in nuclease resistance (<xref ref-type="bibr" rid="B34">34</xref>). This study further evaluates the nuclease resistance of fully 2&#x02032;F-ANA-modified thrombin-binding aptamers (PG1&#x02013;14, <xref ref-type="table" rid="T1">Table 1</xref>). The data clearly shows that 2&#x02032;F-ANA modified aptamers have enhanced half-lives in 10% FBS (in some cases &#x0003e;48-fold compared with PG1, Figure S6 in Supplementary Data and <xref ref-type="table" rid="T1">Table 1</xref>) but nuclease stability is found to be dependent on both the position (esp. <italic>syn</italic>-G and <italic>anti</italic>-G) and number of 2&#x02032;F-ANA residues within the oligonucleotide backbone. For example, replacing <italic>anti</italic>-Gs with 2&#x02032;F-ANA (PG3 and PG4) increases the half-lives to 4.8 and 9.4&#x02009;h, respectively, while replacing <italic>syn</italic>-Gs with 2&#x02032;F-ANA (PG5 and PG6) does not yield much gain in biostability with half-life increases of only 0.8 and 0.6&#x02009;h, respectively, comparable to the DNA aptamer (PG1) (Figure S6 in Supplementary Data and <xref ref-type="table" rid="T1">Table 1</xref>). These differences could be justified by the previous finding that PG5 and PG6 only form insignificant G-quadruplex structures (<xref ref-type="fig" rid="F2">Figure 2</xref>D) due to the unfavored conformation of the perturbed <italic>syn</italic>-Gs. It is expected that a complex structure should be less accessible for nuclease attack compared to dissociated or &#x02018;open&#x02019; oligonucleotides. Furthermore, the nuclease stability of PG13 and PG14 is enhanced over PG1 by a factor of 4&#x02013;7 with only four 2&#x02032;F-ANA incorporated (<xref ref-type="table" rid="T1">Table 1</xref>). Modification of the loop residues of stable structures (e.g. PG4, PG8) may have a double effect since the increased stability of the duplex would be combined with protection of the nucleotides most exposed to endonuclease attack.</p></sec><sec><title>Binding affinity of 2&#x02032;F-ANA-modified thrombin-binding aptamers with thrombin</title><p>As mentioned in the &#x02018;Introduction&#x02019; section, the structure of the thrombin-binding aptamer is very sensitive to chemical modifications, which often undermine its thermal stability and/or binding activity (<xref ref-type="bibr" rid="B31">31</xref>). Thus, a final experiment in this study was conducted using nitrocellulose filter binding assays to assess the effect of 2&#x02032;F-ANA modifications on the thrombin binding affinity. Data are presented in <xref ref-type="table" rid="T1">Table 1</xref> and in <xref ref-type="fig" rid="F8">Figure 8</xref>. ssDNA (P8) and hairpin (H1) controls show no binding to thrombin as expected (<xref ref-type="bibr" rid="B18">18</xref>). Binding of 2&#x02032;F-ANA aptamers to thrombin is always adversely affected by 2&#x02032;F-ANA modifications on G-quartets themselves, whether <italic>syn</italic>- or <italic>anti</italic>-Gs are modified (PG2-PG6). Some loop modifications with 2&#x02032;F-ANA also disfavor thrombin binding (PG8&#x02013;PG12). However, two loop-modified aptamers (PG13 and PG14, <xref ref-type="table" rid="T1">Table 1</xref>) show a 4&#x02013;5-fold enhancement in thrombin-binding affinity. This conclusion should bear in mind that while these two aptamers may have enhanced binding affinity, the slope of the concentration response is not as sharp as that for the native PG1. Therefore, this study reveals the first 2&#x02032;F-ANA modified thrombin-binding aptamers to combine enhanced thermal and nuclease stability with apparently slightly stronger binding affinity. Previous structural studies by NMR and crystallography suggest that the loop moieties would change conformation during binding to thrombin (<xref ref-type="bibr" rid="B18">18</xref>). The TGT loop is involved with the fibrinogen exosite and two TT loops could interact with the heparin exosite. It seems therefore that two 2&#x02032;F-ANA-T residues when present in one of the TT loops and the TGT loop enhance thrombin binding.
<fig id="F8" position="float"><label>Figure 8.</label><caption><p>Binding affinity of selected aptamers with human thrombin assessed by nitrocellulose filter binding assays.</p></caption><graphic xlink:href="gkm520f8"/></fig></p></sec></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>In the present study 2&#x02032;F-ANA modified oligonucleotides were investigated based on a thrombin-binding DNA aptamer d(G<sub>2</sub>T<sub>2</sub>G<sub>2</sub>TGTG<sub>2</sub>T<sub>2</sub>G<sub>2</sub>), an anti-HIV phosphothioate PS-d(T<sub>2</sub>G<sub>4</sub>T<sub>2</sub>) and a DNA telomeric sequence d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>) (<xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>) by UV thermal denaturation and CD experiments. Generally, replacement of <italic>anti</italic>-Gs with 2&#x02032;F-ANA can stabilize a G-quartet requiring <italic>anti</italic>-Gs and maintain the quadruplex conformation, while replacement of <italic>syn</italic>-Gs with 2&#x02032;F-ANA is not favored and results in complete conformational change of the G-quadruplexes. The data shows that appropriate incorporation of 2&#x02032;F-ANA residues into G-quadruplexes leads to an increase in the melting temperature of the complex formed (&#x00394;<italic>T<sub>m</sub></italic> up to &#x0223c;+3&#x000b0;C/2&#x02032;F-ANA modification, <xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>). The structure of thrombin-binding aptamers is stabilized by the presence of potassium ions. Nuclease resistance of 2&#x02032;F-ANA modified thrombin-binding aptamers is increased up to 48-fold in 10% FBS. Two 2&#x02032;F-ANA-modified thrombin-binding aptamers (PG13 and PG14) show a 4&#x02013;5-fold enhancement in binding affinity to thrombin along with increased thermal stability and nuclease resistance. Therefore, the impact of 2&#x02032;F-ANA modifications on G-quartets and loop regions has been demonstrated. The study suggests that 2&#x02032;F-ANA may positively impact oligonucleotide-based therapeutics involving G-quadruplexes.</p></sec><sec sec-type="supplementary-material"><title>SUPPLEMENTARY DATA</title><p>Supplementary Data are available at NAR Online.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We acknowledge financial support through a grant from the Canadian Institutes of Health Research (CIHR) and Topigen Pharmaceuticals, Inc. CGP acknowledges support from a FQRNT fellowship and a Clifford Wong McGill Major Fellowship. We thank J. Watts, R. Donga and J. Lackey for helpful feedback during the preparation of this manuscript. C. G. P. and M.J.D. are recipients of the Carl Winkler Dissertation Award (McGill University) and Bernard Belleau Award (Canadian Society for Chemistry), respectively. Funding to pay the Open Access publication charges for this article was provided by CIHR (Canadian Institutes of Health Research). Dedicated to Hermano Juan Ant&#x000f3;n on the occasion of his 61th birthday.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellert</surname><given-names>M</given-names></name><name><surname>Lipsett</surname><given-names>MN</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name></person-group><article-title>Helix formation by guanylic acid</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1962</year><volume>48</volume><fpage>2013</fpage><lpage>2018</lpage><pub-id pub-id-type="pmid">13947099</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>D</given-names></name><name><surname>Gilbert</surname><given-names>W</given-names></name></person-group><article-title>Formation of parallel 4-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis</article-title><source>Nature</source><year>1988</year><volume>334</volume><fpage>364</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">3393228</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuerk</surname><given-names>C</given-names></name><name><surname>Gold</surname><given-names>L</given-names></name></person-group><article-title>Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase</article-title><source>Science</source><year>1990</year><volume>249</volume><fpage>505</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">2200121</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellington</surname><given-names>AD</given-names></name><name><surname>Szostak</surname><given-names>JW</given-names></name></person-group><article-title>I<italic>n vitro</italic> selection of RNA molecules that bind specific ligands</article-title><source>Nature</source><year>1990</year><volume>346</volume><fpage>818</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">1697402</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>GF</given-names></name></person-group><article-title>Amplification, mutation and selection of catalytic RNA</article-title><source>Gene</source><year>1989</year><volume>82</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">2684778</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>LC</given-names></name><name><surname>Griffin</surname><given-names>LC</given-names></name><name><surname>Latham</surname><given-names>JA</given-names></name><name><surname>Vermaas</surname><given-names>EH</given-names></name><name><surname>Toole</surname><given-names>JJ</given-names></name></person-group><article-title>Selection of single-stranded DNA molecules that bind and inhibit human thrombin</article-title><source>Nature</source><year>1992</year><volume>355</volume><fpage>564</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">1741036</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>JR</given-names></name><name><surname>Vickers</surname><given-names>TA</given-names></name><name><surname>Roberson</surname><given-names>JL</given-names></name><name><surname>Buckheit</surname><given-names>RW</given-names></name><name><surname>Klimkait</surname><given-names>T</given-names></name><name><surname>Debaets</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>PW</given-names></name><name><surname>Rayner</surname><given-names>B</given-names></name><name><surname>Imbach</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Combinatorially selected guanosine-quartet structure is a potent inhibitor of human-immunodeficiency-virus envelope-mediated cell-fusion</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>1356</fpage><lpage>1360</lpage><pub-id pub-id-type="pmid">7906414</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>AT</given-names></name><name><surname>Kuryavyi</surname><given-names>V</given-names></name><name><surname>Ma</surname><given-names>JB</given-names></name><name><surname>Faure</surname><given-names>A</given-names></name><name><surname>Andreola</surname><given-names>ML</given-names></name><name><surname>Patel</surname><given-names>DJ</given-names></name></person-group><article-title>An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>634</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">15637158</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>NJ</given-names></name><name><surname>Hogan</surname><given-names>ME</given-names></name></person-group><article-title>Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug</article-title><source>J. Biol. Chem</source><year>1998</year><volume>273</volume><fpage>34992</fpage><lpage>34999</lpage><pub-id pub-id-type="pmid">9857031</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borman</surname><given-names>S</given-names></name></person-group><article-title>Targeting telomerase</article-title><source>Chem. Eng. News</source><year>2006</year><volume>84</volume><fpage>32</fpage><lpage>33</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keniry</surname><given-names>MA</given-names></name></person-group><article-title>Quadruplex structures in nucleic acids</article-title><source>Biopolymers</source><year>2000</year><volume>56</volume><fpage>123</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">11745109</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>JR</given-names></name></person-group><article-title>G-quartet structures in telomeric DNA</article-title><source>Annu. Rev. Biophys. Biomol. Struct</source><year>1994</year><volume>23</volume><fpage>703</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">7919797</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerwin</surname><given-names>SM</given-names></name></person-group><article-title>G-quadruplex DNA as a target for drug design</article-title><source>Curr. Pharm. Des</source><year>2000</year><volume>6</volume><fpage>441</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">10788591</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze</surname><given-names>P</given-names></name><name><surname>Macaya</surname><given-names>RF</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name></person-group><article-title>Three-dimensional solution structure of the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG)</article-title><source>J. Mol. Biol</source><year>1994</year><volume>235</volume><fpage>1532</fpage><lpage>1547</lpage><pub-id pub-id-type="pmid">8107090</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macaya</surname><given-names>RF</given-names></name><name><surname>Schultze</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>FW</given-names></name><name><surname>Roe</surname><given-names>JA</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name></person-group><article-title>Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1993</year><volume>90</volume><fpage>3745</fpage><lpage>3749</lpage><pub-id pub-id-type="pmid">8475124</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Mccurdy</surname><given-names>S</given-names></name><name><surname>Shea</surname><given-names>RG</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Bolton</surname><given-names>PH</given-names></name></person-group><article-title>A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>1899</fpage><lpage>1904</lpage><pub-id pub-id-type="pmid">8448147</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Krawczyk</surname><given-names>SH</given-names></name><name><surname>Bischofberger</surname><given-names>N</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Bolton</surname><given-names>PH</given-names></name></person-group><article-title>The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>11285</fpage><lpage>11292</lpage><pub-id pub-id-type="pmid">8218193</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>K</given-names></name><name><surname>Padmanabhan</surname><given-names>KP</given-names></name><name><surname>Ferrara</surname><given-names>JD</given-names></name><name><surname>Sadler</surname><given-names>JE</given-names></name><name><surname>Tulinsky</surname><given-names>A</given-names></name></person-group><article-title>The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer</article-title><source>J. Biol. Chem</source><year>1993</year><volume>268</volume><fpage>17651</fpage><lpage>17654</lpage><pub-id pub-id-type="pmid">8102368</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>K</given-names></name><name><surname>Tulinsky</surname><given-names>A</given-names></name></person-group><article-title>An ambiguous structure of a DNA 15-mer thrombin complex</article-title><source>Acta Crystallogr. D Biol. Crystallogr</source><year>1996</year><volume>D52</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">15299700</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name><name><surname>Yeates</surname><given-names>TO</given-names></name></person-group><article-title>Reconciliation of the x-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG)</article-title><source>J. Mol. Biol</source><year>1996</year><volume>256</volume><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">8604127</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>FW</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name></person-group><article-title>Refined solution structure of the dimeric quadruplex formed from the <italic>Oxytricha</italic> telomeric oligonucleotide d(GGGGTTTTGGGG)</article-title><source>Structure</source><year>1994</year><volume>2</volume><fpage>221</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">8069635</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>FW</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name></person-group><article-title>Quadruplex structure of <italic>Oxytricha</italic> telomeric DNA oligonucleotides</article-title><source>Nature</source><year>1992</year><volume>356</volume><fpage>164</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">1545871</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Ratliff</surname><given-names>R</given-names></name><name><surname>Moyzis</surname><given-names>R</given-names></name><name><surname>Rich</surname><given-names>A</given-names></name></person-group><article-title>Crystal structure of 4 stranded <italic>Oxytricha</italic> telomeric DNA</article-title><source>Nature</source><year>1992</year><volume>356</volume><fpage>126</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">1545863</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Parkinson</surname><given-names>GN</given-names></name><name><surname>Neidle</surname><given-names>S</given-names></name></person-group><article-title>Crystal structure of the potassium form of an Oxytricha nova G-quadruplex</article-title><source>J. Mol. Biol</source><year>2002</year><volume>320</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">12079378</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze</surname><given-names>P</given-names></name><name><surname>Hud</surname><given-names>NV</given-names></name><name><surname>Smith</surname><given-names>FW</given-names></name><name><surname>Feigon</surname><given-names>J</given-names></name></person-group><article-title>The effect of sodium, potassium and ammonium ions on the conformation of the dimeric quadruplex formed by the <italic>Oxytricha nova</italic> telomere repeat oligonucleotide d(G<sub>4</sub>T<sub>4</sub>G<sub>4</sub>)</article-title><source>Nucleic Acids Res</source><year>1999</year><volume>27</volume><fpage>3018</fpage><lpage>3028</lpage><pub-id pub-id-type="pmid">10454595</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardin</surname><given-names>CC</given-names></name><name><surname>Perry</surname><given-names>AG</given-names></name><name><surname>White</surname><given-names>K</given-names></name></person-group><article-title>Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids</article-title><source>Biopolymers</source><year>2000</year><volume>56</volume><fpage>147</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">11745110</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckel</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>G</given-names></name></person-group><article-title>Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases</article-title><source>J. Am. Chem. Soc</source><year>2005</year><volume>127</volume><fpage>822</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">15656605</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Giusto</surname><given-names>DA</given-names></name><name><surname>King</surname><given-names>GC</given-names></name></person-group><article-title>Construction, stability, and activity of multivalent circular anticoagulant aptamers</article-title><source>J. Biol. Chem</source><year>2004</year><volume>279</volume><fpage>46483</fpage><lpage>46489</lpage><pub-id pub-id-type="pmid">15322086</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buijsman</surname><given-names>RC</given-names></name><name><surname>Schipperijn</surname><given-names>JWJ</given-names></name><name><surname>Kuyl-Yeheskiely</surname><given-names>E</given-names></name><name><surname>Van Der Marel</surname><given-names>GA</given-names></name><name><surname>Van Boeckel</surname><given-names>CAA</given-names></name><name><surname>Van Boom</surname><given-names>JH</given-names></name></person-group><article-title>Design and synthesis of a possible mimic of a thrombin-binding DNA aptamer</article-title><source>Bioorg. Med. Chem. Lett</source><year>1997</year><volume>7</volume><fpage>2027</fpage><lpage>2032</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosemeyer</surname><given-names>H</given-names></name><name><surname>Mokrosch</surname><given-names>V</given-names></name><name><surname>Jawalekar</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>E-M</given-names></name><name><surname>Seela</surname><given-names>F</given-names></name></person-group><article-title>Single-stranded DNA: replacement of canonical by base-modified nucleosides in the minihairpin 5&#x02032;-d(GCGAAGC)-3&#x02032; and constructs with the aptamer 5&#x02032;-d(GGTTGGTGTGGTTGG)-3&#x02032;</article-title><source>Helv. Chim. Acta</source><year>2004</year><volume>87</volume><fpage>536</fpage><lpage>553</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacca</surname><given-names>B</given-names></name><name><surname>Lacroix</surname><given-names>L</given-names></name><name><surname>Mergny</surname><given-names>J-L</given-names></name></person-group><article-title>The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotides</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>1182</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">15731338</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebruska</surname><given-names>LL</given-names></name><name><surname>Maher</surname><given-names>LJ</given-names><suffix>III</suffix></name></person-group><article-title>Selection and characterization of an RNA decoy for rranscription factor NF-kB</article-title><source>Biochemistry</source><year>1999</year><volume>38</volume><fpage>3168</fpage><lpage>3174</lpage><pub-id pub-id-type="pmid">10074372</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trempe</surname><given-names>J-F</given-names></name><name><surname>Wilds</surname><given-names>CJ</given-names></name><name><surname>Denisov</surname><given-names>AY</given-names></name><name><surname>Pon</surname><given-names>RT</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name><name><surname>Gehring</surname><given-names>K</given-names></name></person-group><article-title>NMR solution structure of an oligonucleotide hairpin with a 2&#x02032;F-ANA/RNA stem: implications for RNase H specificity toward DNA/RNA hybrid duplexes</article-title><source>J. Am. Chem. Soc</source><year>2001</year><volume>123</volume><fpage>4896</fpage><lpage>4903</lpage><pub-id pub-id-type="pmid">11457316</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalota</surname><given-names>A</given-names></name><name><surname>Karabon</surname><given-names>L</given-names></name><name><surname>Swider</surname><given-names>CR</given-names></name><name><surname>Viazovkina</surname><given-names>E</given-names></name><name><surname>Elzagheid</surname><given-names>M</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name><name><surname>Gewirtz</surname><given-names>AM</given-names></name></person-group><article-title>2&#x02032;-Deoxy-2&#x02032;-fluoro-beta-D-arabinonucleic acid (2&#x02032;F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>451</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">16421272</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilds</surname><given-names>CJ</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><article-title>2&#x02032;-Deoxy-2&#x02032;-fluoro-&#x003b2;-D-arabinonucleosides and olignucleotides (2&#x02032;F-ANA): synthesis and physicochemical studies</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><fpage>3625</fpage><lpage>3635</lpage><pub-id pub-id-type="pmid">10982885</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilds</surname><given-names>CJ</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><article-title>Duplex recognition by oligonucleotides containing 2&#x02032;-deoxy-2&#x02032;-fluoro-D-arabinose and 2&#x02032;-deoxy-2&#x02032;-fluoro-D-ribose. Intermolecular 2&#x02032;-OH-phosphate contacts versus sugar puckering in the stabilization of triple-helical complexes</article-title><source>Bioconjug. Chem</source><year>1999</year><volume>10</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">10077480</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilds</surname><given-names>CJ</given-names></name></person-group><source>Ph.D. Thesis</source><year>2000</year><publisher-loc>Montreal</publisher-loc><publisher-name>McGill University</publisher-name></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname><given-names>C-N</given-names></name><name><surname>Viazovkina</surname><given-names>E</given-names></name><name><surname>Min</surname><given-names>K-L</given-names></name><name><surname>Nagy</surname><given-names>E</given-names></name><name><surname>Wilds</surname><given-names>CJ</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name><name><surname>Parniak</surname><given-names>MA</given-names></name></person-group><article-title>Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2&#x02032;-deoxy-2&#x02032;-fluoro-D-arabinose and 2&#x02032;-deoxyribose nucleotides</article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><fpage>3457</fpage><lpage>3467</lpage><pub-id pub-id-type="pmid">11876654</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowler</surname><given-names>T</given-names></name><name><surname>Bergeron</surname><given-names>D</given-names></name><name><surname>Tedeschi</surname><given-names>AL</given-names></name><name><surname>Paquet</surname><given-names>L</given-names></name><name><surname>Ferrari</surname><given-names>N</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><article-title>Improvements in siRNA properties mediated by 2&#x02032;-deoxy-2&#x02032;-fluoro-beta-D-arabinonucleic acid (FANA)</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>1669</fpage><lpage>1675</lpage><pub-id pub-id-type="pmid">16554553</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>JK</given-names></name><name><surname>Choubdar</surname><given-names>N</given-names></name><name><surname>Sadalapure</surname><given-names>K</given-names></name><name><surname>Robert</surname><given-names>F</given-names></name><name><surname>Wahba</surname><given-names>AS</given-names></name><name><surname>Pelletier</surname><given-names>J</given-names></name><name><surname>Pinto</surname><given-names>BM</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><article-title>2&#x02032;-Fluoro-4&#x02032;-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>1441</fpage><lpage>1451</lpage><pub-id pub-id-type="pmid">17284457</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Viazovkina</surname><given-names>EV</given-names></name><name><surname>Mangos</surname><given-names>MM</given-names></name><name><surname>Elzagheid</surname><given-names>MI</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><source>Current Protocols in Nucleic Acid Chemistry</source><year>2002</year><publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name><fpage>4.15.11</fpage><lpage>22</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Shafer</surname><given-names>RH</given-names></name></person-group><article-title>Effect of loop sequence and size on DNA aptamer stability</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>1462</fpage><lpage>1468</lpage><pub-id pub-id-type="pmid">10684628</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>JR</given-names></name><name><surname>Davis</surname><given-names>PW</given-names></name><name><surname>Freier</surname><given-names>SM</given-names></name></person-group><article-title>Kinetics of G-quartet-mediated tetramer formation</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>8002</fpage><lpage>8008</lpage><pub-id pub-id-type="pmid">8672504</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Kallenbach</surname><given-names>NR</given-names></name></person-group><article-title>Thermodynamics of G-tetraplex formation by telomeric DNAs</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>598</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">8422371</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantor</surname><given-names>CR</given-names></name><name><surname>Warshaw</surname><given-names>MM</given-names></name><name><surname>Shapiro</surname><given-names>H</given-names></name></person-group><article-title>Oligonucleotide interactions. 3. Circular dichroism studies of conformation of deoxyoligonucleotides</article-title><source>Biopolymers</source><year>1970</year><volume>9</volume><fpage>1059</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">5449435</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Galarneau</surname><given-names>A</given-names></name><name><surname>Min</surname><given-names>K-L</given-names></name><name><surname>Mangos</surname><given-names>MM</given-names></name><name><surname>Damha</surname><given-names>MJ</given-names></name></person-group><source>Methods Mol. Biol</source><year>2005</year><volume>Vol. 288</volume><publisher-loc>NJ, United States</publisher-loc><publisher-name>Totowa</publisher-name><fpage>65</fpage><lpage>80</lpage></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimjee</surname><given-names>SM</given-names></name><name><surname>Rusconi</surname><given-names>CP</given-names></name><name><surname>Sullenger</surname><given-names>BA</given-names></name></person-group><article-title>Aptamers: an emerging class of therapeutics</article-title><source>Annu. Rev. Med</source><year>2005</year><volume>56</volume><fpage>555</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">15660527</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brody</surname><given-names>EN</given-names></name><name><surname>Gold</surname><given-names>L</given-names></name></person-group><article-title>Aptamers as therapeutic and diagnostic agents</article-title><source>Rev. Mol. Biotechnol</source><year>2000</year><volume>74</volume><fpage>5</fpage><lpage>13</lpage></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RR</given-names></name><name><surname>Sullenger</surname><given-names>BA</given-names></name><name><surname>Rusconi</surname><given-names>CP</given-names></name></person-group><article-title>Developing aptamers into therapeutics</article-title><source>J. Clin. Invest</source><year>2000</year><volume>106</volume><fpage>929</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">11032851</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestourie</surname><given-names>C</given-names></name><name><surname>Tavitian</surname><given-names>B</given-names></name><name><surname>Duconge</surname><given-names>F</given-names></name></person-group><article-title>Aptamers against extracellular targets for in vivo applications</article-title><source>Biochimie</source><year>2005</year><volume>87</volume><fpage>921</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">15963620</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolte</surname><given-names>A</given-names></name><name><surname>Klussmann</surname><given-names>S</given-names></name><name><surname>Bald</surname><given-names>R</given-names></name><name><surname>Erdmann</surname><given-names>VA</given-names></name><name><surname>Fuerste</surname><given-names>JP</given-names></name></person-group><article-title>Mirror-design of L-oligonucleotide ligands binding to L-arginine</article-title><source>Nat. Biotechnol</source><year>1996</year><volume>14</volume><fpage>1116</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">9631062</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruckman</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>LS</given-names></name><name><surname>Beeson</surname><given-names>J</given-names></name><name><surname>Waugh</surname><given-names>S</given-names></name><name><surname>Gillette</surname><given-names>WL</given-names></name><name><surname>Henninger</surname><given-names>DD</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name><name><surname>Janjic</surname><given-names>N</given-names></name></person-group><article-title>2&#x02032;-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain</article-title><source>J. Biol. Chem</source><year>1998</year><volume>273</volume><fpage>20556</fpage><lpage>20567</lpage><pub-id pub-id-type="pmid">9685413</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lato</surname><given-names>SM</given-names></name><name><surname>Ozerova</surname><given-names>NDS</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Sergueeva</surname><given-names>Z</given-names></name><name><surname>Shaw</surname><given-names>BR</given-names></name><name><surname>Burke</surname><given-names>DH</given-names></name></person-group><article-title>Boron-containing aptamers to ATP</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>1401</fpage><lpage>1407</lpage><pub-id pub-id-type="pmid">11884639</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Minakawa</surname><given-names>N</given-names></name><name><surname>Komatsu</surname><given-names>Y</given-names></name><name><surname>Kamiya</surname><given-names>H</given-names></name><name><surname>Ogawa</surname><given-names>N</given-names></name><name><surname>Harashima</surname><given-names>H</given-names></name><name><surname>Matsuda</surname><given-names>A</given-names></name></person-group><article-title>New NTP analogs: the synthesis of 4&#x02032;-thioUTP and 4&#x02032;-thioCTP and their utility for SELEX</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>2942</fpage><lpage>2951</lpage><pub-id pub-id-type="pmid">15914669</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhaveri</surname><given-names>S</given-names></name><name><surname>Olwin</surname><given-names>B</given-names></name><name><surname>Ellington</surname><given-names>AD</given-names></name></person-group><article-title><italic>In vitro</italic> selection of phosphorothiolated aptamers</article-title><source>Bioorg. Med. Chem. Lett</source><year>1998</year><volume>8</volume><fpage>2285</fpage><lpage>2290</lpage><pub-id pub-id-type="pmid">9873529</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagratis</surname><given-names>NC</given-names></name><name><surname>Bell</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>Y-F</given-names></name><name><surname>Jennings</surname><given-names>S</given-names></name><name><surname>Fitzwater</surname><given-names>T</given-names></name><name><surname>Jellinek</surname><given-names>D</given-names></name><name><surname>Dang</surname><given-names>C</given-names></name></person-group><article-title>Potent 2&#x02032;-amino-, and 2&#x02032;-fluoro-2&#x02032;-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor</article-title><source>Nat. Biotechnol</source><year>1997</year><volume>15</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">9035109</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>EWM</given-names></name><name><surname>Shima</surname><given-names>DT</given-names></name><name><surname>Calias</surname><given-names>P</given-names></name><name><surname>Cunningham</surname><given-names>ET</given-names></name><name><surname>Guyer</surname><given-names>DR</given-names></name><name><surname>Adamis</surname><given-names>AP</given-names></name></person-group><article-title>Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease</article-title><source>Nat. Rev. Drug Discov</source><year>2006</year><volume>5</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">16518379</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mergny</surname><given-names>JL</given-names></name><name><surname>Phan</surname><given-names>AT</given-names></name><name><surname>Lacroix</surname><given-names>L</given-names></name></person-group><article-title>Following G-quartet formation by UV-spectroscopy</article-title><source>FEBS Lett</source><year>1998</year><volume>435</volume><fpage>74</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">9755862</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgilio</surname><given-names>A</given-names></name><name><surname>Esposito</surname><given-names>V</given-names></name><name><surname>Randazzo</surname><given-names>A</given-names></name><name><surname>Mayol</surname><given-names>L</given-names></name><name><surname>Galeone</surname><given-names>A</given-names></name></person-group><article-title>8-Methyl-2&#x02032;-deoxyguanosine incorporation into parallel DNA quadruplex structures</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>6188</fpage><lpage>6195</lpage><pub-id pub-id-type="pmid">16257981</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>V</given-names></name><name><surname>Randazzo</surname><given-names>A</given-names></name><name><surname>Piccialli</surname><given-names>G</given-names></name><name><surname>Petraccone</surname><given-names>L</given-names></name><name><surname>Giancola</surname><given-names>C</given-names></name><name><surname>Mayol</surname><given-names>L</given-names></name></person-group><article-title>Effects of an 8-bromodeoxyguanosine incorporation on the parallel quadruplex structure [d(TGGGT)](4)</article-title><source>Org. Biomol. Chem</source><year>2004</year><volume>2</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">14747859</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>CF</given-names></name><name><surname>Shafer</surname><given-names>RH</given-names></name></person-group><article-title>Engineering the quadruplex fold: Nucleoside conformation determines both folding topology and molecularity in guanine quadruplexes</article-title><source>J. Am. Chem. Soc</source><year>2006</year><volume>128</volume><fpage>5966</fpage><lpage>5973</lpage><pub-id pub-id-type="pmid">16637665</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominick</surname><given-names>PK</given-names></name><name><surname>Jarstfer</surname><given-names>MB</given-names></name></person-group><article-title>A conformationally constrained nucleotide analogue controls the folding topology of a DNA G-quadruplex</article-title><source>J. Am. Chem. Soc</source><year>2004</year><volume>126</volume><fpage>5050</fpage><lpage>5051</lpage><pub-id pub-id-type="pmid">15099071</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapse</surname><given-names>AM</given-names></name><name><surname>Snyder</surname><given-names>G</given-names></name></person-group><article-title>Ab initio studies of the antiviral drug 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl) thymine</article-title><source>Cancer Invest</source><year>1985</year><volume>3</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">3995376</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkinson</surname><given-names>GN</given-names></name><name><surname>Lee</surname><given-names>MPH</given-names></name><name><surname>Neidle</surname><given-names>S</given-names></name></person-group><article-title>Crystal structure of parallel quadruplexes from human telomeric DNA</article-title><source>Nature</source><year>2002</year><volume>417</volume><fpage>876</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">12050675</pub-id></element-citation></ref></ref-list></back></article>
